UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): November 18, 2009
BIOANALYTICAL
SYSTEMS, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Indiana
|
|
0-23357
|
|
35-1345024
|
(State
or other
jurisdiction
of
incorporation
or
organization)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer Identification
No.)
|
2701
KENT AVENUE
WEST
LAFAYETTE, INDIANA
|
|
47906-1382
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (765) 463-4527
Item
3.01. Notice of Delisting or Failure to Satisfy a Continued
Listing Rule or Standard; Transfer of Listing.
On
November 18, 2009, Bioanaltytical Systems, Inc. (the "Company") received a
letter from the NASDAQ Listing Qualification Department (the "Letter") stating
that the Company’s application to transfer its common shares to the Capital
Market has been approved. The transfer will occur on November
20, 2009.
The
Company had previously been informed by the NASDAQ Stock Market that it did not
meet minimum market value of publicly held shares and minimum bid price per
share requirements. As a result of an increase in the market value of
its stock, and lower minimum market value of publicly held shares for the
Capital Market, the Company is now in compliance with the Capital Market
requirements.
On
November 19, 2009 the Company issued a press release announcing receipt of the
Letter. A copy of that press release is attached as Exhibit 99.1 and
is incorporated herein by reference.
Item
9.01. Financial Statements and Exhibits.
99.1 Bioanalytical
Systems, Inc. press release, issued November 19, 2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Bioanalytical
Systems, Inc. |
|
|
|
|
|
Date: November
19, 2009
|
By:
|
/s/ Michael R. Cox
|
|
|
|
Michael
R. Cox
|
|
|
|
Vice
President, Finance and Administration, Chief
Financial
Officer and Treasurer
|
|
Exhibit
Index
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Bioanalytical
Systems, Inc. press release, issued November 19,
2009.
|